These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 19672661)

  • 1. IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis.
    Li D; Yan D; Tang H; Zhou C; Fan J; Li S; Wang X; Xia J; Huang F; Qiu G; Peng Z
    Ann Surg Oncol; 2009 Dec; 16(12):3499-506. PubMed ID: 19672661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Msi-1 is a predictor of survival and a novel therapeutic target in colon cancer.
    Li D; Peng X; Yan D; Tang H; Huang F; Yang Y; Peng Z
    Ann Surg Oncol; 2011 Jul; 18(7):2074-83. PubMed ID: 21442350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IMP3 combined with CD44s, a novel predictor for prognosis of patients with hepatocellular carcinoma.
    Hu S; Wu X; Zhou B; Xu Z; Qin J; Lu H; Lv L; Gao Y; Deng L; Yin J; Li G
    J Cancer Res Clin Oncol; 2014 Jun; 140(6):883-93. PubMed ID: 24647926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study.
    Jiang Z; Chu PG; Woda BA; Rock KL; Liu Q; Hsieh CC; Li C; Chen W; Duan HO; McDougal S; Wu CL
    Lancet Oncol; 2006 Jul; 7(7):556-64. PubMed ID: 16814207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IMP3 expression in small-intestine neuroendocrine neoplasms: a new predictor of recurrence.
    Massironi S; Del Gobbo A; Cavalcoli F; Fiori S; Conte D; Pellegrinelli A; Milione M; Ferrero S
    Endocrine; 2017 Nov; 58(2):360-367. PubMed ID: 28210937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph node CXCL17 messenger RNA: A new prognostic biomarker for colon cancer.
    Rashad Y; Olsson L; Israelsson A; Öberg Å; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
    Tumour Biol; 2018 Sep; 40(9):1010428318799251. PubMed ID: 30198422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
    Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
    J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IMP3 Predicts Invasion and Prognosis in Human Lung Adenocarcinoma.
    Yan J; Wei Q; Jian W; Qiu B; Wen J; Liu J; Fu B; Zhou X; Zhao T
    Lung; 2016 Feb; 194(1):137-46. PubMed ID: 26608347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma.
    Hoffmann NE; Sheinin Y; Lohse CM; Parker AS; Leibovich BC; Jiang Z; Kwon ED
    Cancer; 2008 Apr; 112(7):1471-9. PubMed ID: 18260086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffuse expression of RNA-binding protein IMP3 predicts high-stage lymph node metastasis and poor prognosis in colorectal adenocarcinoma.
    Yuan RH; Wang CC; Chou CC; Chang KJ; Lee PH; Jeng YM
    Ann Surg Oncol; 2009 Jun; 16(6):1711-9. PubMed ID: 19357927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of insulin-like growth factor II mRNA-binding protein 3 (IMP3) has negative prognostic impact on early invasive (pT1) adenocarcinoma of the esophagus.
    Plum PS; Ulase D; Bollschweiler E; Chon SH; Berlth F; Zander T; Alakus H; Hölscher AH; Bruns CJ; Schallenberg S; Quaas A; Loeser H
    J Cancer Res Clin Oncol; 2018 Sep; 144(9):1731-1739. PubMed ID: 29974234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synuclein gamma predicts poor clinical outcome in colon cancer with normal levels of carcinoembryonic antigen.
    Liu C; Dong B; Lu A; Qu L; Xing X; Meng L; Wu J; Eric Shi Y; Shou C
    BMC Cancer; 2010 Jul; 10():359. PubMed ID: 20604972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of Molecular Detection of Lymph Node Metastases After Curative Resection of Stage II Colon Cancer: A Systematic Pooled Data Analysis.
    Gill S; Haince JF; Shi Q; Pavey ES; Beaudry G; Sargent DJ; Fradet Y
    Clin Colorectal Cancer; 2015 Jun; 14(2):99-105. PubMed ID: 25619805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma.
    Jeng YM; Chang CC; Hu FC; Chou HY; Kao HL; Wang TH; Hsu HC
    Hepatology; 2008 Oct; 48(4):1118-27. PubMed ID: 18802962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of insulin-like growth factor II mRNA binding protein 3 in patients treated with radical prostatectomy.
    Chromecki TF; Cha EK; Pummer K; Scherr DS; Tewari AK; Sun M; Fajkovic H; Roehrborn CG; Ashfaq R; Karakiewicz PI; Shariat SF
    BJU Int; 2012 Jul; 110(1):63-8. PubMed ID: 22077633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective Mismatch Repair Status was not Associated with DFS and OS in Stage II Colon Cancer Treated with Adjuvant Chemotherapy.
    Kim JE; Hong YS; Kim HJ; Kim KP; Lee JL; Park SJ; Lim SB; Park IJ; Kim CW; Yoon YS; Yu CS; Kim JC; Hoon KJ; Kim TW
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S630-7. PubMed ID: 26271397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CIAPIN1 in human colorectal cancer and its correlation with prognosis.
    Shi H; Zhou Y; Liu H; Chen C; Li S; Li N; Li X; Zhang X; Zhang H; Wang W; Zhao Q
    BMC Cancer; 2010 Sep; 10():477. PubMed ID: 20815902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular testing for lymph node metastases as a determinant of colon cancer recurrence: results from a retrospective multicenter study.
    Sargent DJ; Shi Q; Gill S; Louvet C; Everson RB; Kellner U; Clancy TE; Pipas JM; Resnick MB; Meyers MO; Wu TT; Huntsman D; Validire P; Farooq U; Pavey ES; Beaudry G; Haince JF; Fradet Y
    Clin Cancer Res; 2014 Aug; 20(16):4361-9. PubMed ID: 24919572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of tissue and circulating levels of IMP3 in prostate cancer.
    Szarvas T; Tschirdewahn S; Niedworok C; Kramer G; Sevcenco S; Reis H; Shariat SF; Rübben H; vom Dorp F
    Int J Cancer; 2014 Oct; 135(7):1596-604. PubMed ID: 24615121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncofetal protein, IMP-3, a potential marker for prediction of postoperative peritoneal dissemination in gastric adenocarcinoma.
    Okada K; Fujiwara Y; Nakamura Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Takahashi T; Mori M; Doki Y
    J Surg Oncol; 2012 Jun; 105(8):780-5. PubMed ID: 22012575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.